companydata.dkREFLAB ApS: Financial statements 2012
CVR: 15322586
REFLAB ApS (CVR 15322586) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 2,528,583 and a net result of DKK -64,717. Equity amounted to DKK 2,682,799. The solvency ratio was 75.7%.
- Gross Profit
- 2,528,583 kr.
- Profit/Loss
- -64,717 kr.
- Equity
- 2,682,799 kr.
- Total Assets
- 3,542,756 kr.
How creditworthy is REFLAB ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of December 14, 2012, Erik Dahl Jensen is registered as director of REFLAB ApS.
As of December 14, 2012, Per Stahl Skov has stepped down as director of REFLAB ApS.
As of December 14, 2012, Eva Valbjørn Sørensen has stepped down as director of REFLAB ApS.
About REFLAB ApS
REFLAB ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 1991. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named REFERENCELABORATORIET ApS. The management consists of Gert Pynt Andersen. The company is owned by R-Biopharm AG. The company has 7 employees. In 2025, the company reported a gross profit of DKK 4,582,184 and a net result of DKK -1,792,430 compared with DKK 652,577 the year before. Equity amounted to DKK -635,048.